Cosmetic Surgery Market To Reach $202.0 Billion by 2035

Cosmetic surgery market is projected to grow from $60.0?billion in 2025 to $202.0?billion by 2035, registering a CAGR of 12.9% over the forecast period (2026–2035). This growth reflects increasing utilization of surgical aesthetic procedures worldwide, a trend supported by broader access to safe surgical care and rising discretionary healthcare spending. According to the World Health Organization (WHO), global surgical procedures continue to expand as countries invest in surgical infrastructure and training, with an estimated 234 million major surgical procedures performed annually across all categories, underscoring the scale of surgical capacity that cosmetic procedures leverage. (WHO)

Browse the full report description of “Cosmetic Surgery Market Size, Share & Trends Analysis Report, By Procedure Type (Breast Augmentation, Liposuction, Rhinoplasty, Eyelid Surgery, Facelift, Tummy Tuck, Body Lift, Chin & Cheek Enhancement), By End User (Hospitals, Specialty Cosmetic Surgery Clinics, Dermatology Clinics, Medical Spas (MedSpas)), Forecast Period (2026 2035)” at https://www.omrglobal.com/industry-reports/cosmetic-surgery-market

One of the macro drivers of the Cosmetic Surgery market is the prevalence of elective body contouring surgeries, particularly liposuction, which aligns with broader public health patterns of excess weight. According to updated estimates from the U.S. National Center for Health Statistics (NCHS) derived from the National Health and Nutrition Examination Survey, 40.3% of U.S. adults aged 20 and older were classified as having obesity (BMI ?30) between 2021 and 2023, with an additional 31.7% categorized as overweight, indicating widespread elevated body mass that can influence demand for body contouring procedures. (CDC/NCHS) Liposuction remains one of the most frequently performed surgical cosmetic procedures globally, often leading procedural counts ahead of other surgeries, followed by breast augmentation in many markets. (Statista) Breast augmentation continues to represent a significant procedural volume, supported by enhanced implant technologies and expanded reconstructive options that contribute to procedural demand among cosmetic patients as well as those undergoing reconstruction following oncologic surgery.

Innovation Leaders Transforming the Cosmetic Surgery Market

Key players in the Cosmetic Surgery market, including AbbVie Inc. (Allergan Aesthetics), Johnson & Johnson MedTech, Establishment Labs Holdings Inc. (Motiva), Bausch Health Companies Inc., and Cynosure, LLC, are focusing on the development of advanced surgical technologies and digital solutions to improve procedural precision, patient safety, and efficiency. Their initiatives include AI-assisted surgical planning, robot-assisted systems, minimally invasive devices, and digital patient management platforms, along with telemedicine integration. These companies are also pursuing strategic partnerships, product launches, clinical collaborations, and geographical expansion to enhance access to cosmetic and reconstructive procedures across global markets.

• In February 2026, Applied Medical Technology, Inc. received FDA 510(k) clearance for its Explant Express device, designed for the rapid and controlled removal of ruptured silicone breast implants. The device features separable chambers, ergonomic design, and universal suction compatibility, enhancing procedural efficiency, minimizing silicone exposure, and reducing operating time, supporting safer and more efficient breast implant explantation in the cosmetic surgery market.
• In March 2025, BD (Becton, Dickinson and Company) treated the first patient in a multi-center IDE clinical trial evaluating the GalaFLEX LITE Scaffold to reduce capsular contracture recurrence during breast implant revision surgery. The scaffold provides absorbable structural support to improve surgical outcomes and minimize complications, enhancing patient recovery and expanding advanced revision surgery options in the global cosmetic surgery market.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• By Procedure Type
• By End-User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape – AbbVie Inc. (Allergan Aesthetics), Johnson & Johnson MedTech, Establishment Labs Holdings Inc. (Motiva), Bausch Health Companies Inc., and Cynosure, LLC, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cosmetic Surgery Market Report Segment

By Procedure Type

• Breast Augmentation
• Liposuction
• Rhinoplasty (Nose Reshaping)
• Eyelid Surgery (Blepharoplasty)
• Facelift (Rhytidectomy)
• Tummy Tuck (Abdominoplasty)
• Body Lift
• Chin & Cheek Enhancement

By End?User

• Hospitals
• Specialty Cosmetic Surgery Clinics
• Dermatology Clinics
• Medical Spas (MedSpas)

Global Cosmetic Surgery Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia?Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia?Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cosmetic-surgery-market